ReviewCancer journal (Sudbury, Mass.)
Artificial Intelligence in Proton Therapy: What Works, What Does Not, and What Is Next.
Review in Cancer journal (Sudbury, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Artificial intelligence is increasingly shaping the evolution of proton therapy, with applications spanning imaging, treatment planning, quality assurance, adaptive workflows, and outcome modeling. Unlike conventional task-specific algorithms, modern AI methods, including machine learning and deep learning, enable integration of heterogeneous data and capture complex relationships across the clinical workflow. These capabilities are particularly relevant in proton therapy, where sensitivity to range uncertainty, anatomic variation, and biological heterogeneity presents persistent clinical and operational challenges. This review summarizes current and emerging AI applications in proton therapy, including image reconstruction and synthesis, segmentation, dose prediction, robustness and uncertainty management, biological optimization, and adaptive treatment strategies. We also discuss the expanding role of AI in quality assurance and workflow coordination, emphasizing the distinction between task-level automation and workflow-level intelligence. Finally, we address broader considerations related to clinical validation, safety, interpretability, economic value, and access, which will be critical for translating AI-enabled proton therapy into routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.